Management of Mootraghata (Benign Prostatic Hyperplesia)  with herbal remedies- A pilot study by Joyal, Patel et al.
Published online in http://iijam.co.in 
  ISSN: 0976-5921 
International Journal of Ayurvedic Medicine, 2014, 5(1), 102-110 
 
111 
Management of Mootraghata (Benign Prostatic Hyperplesia)  with herbal 
remedies- A pilot study 
 
Research article 
 
Patel Joyal 
1
, Dudhamal TS 
2*
, Gupta SK 
3
, Mahanta VD
4 
 
1. PG Scholar, 2. Assistant Professor, 3. Associate Professor, 4. Assistant Professor  
Department of Shalyatantra, I.P.G.T. and R.A. 
Gujarat Ayurved University, Jamnagar, Gujarat-361 008, India 
 
Abstract: 
Mootraghata (Benign Prostatic Hyperplesia i.e. BPH) is a senile disorder affects 
above 40 years of age, having symptoms like retention, incomplete voiding, dribbling, 
hesitancy, incontinence of urine, etc. Conservative treatment and surgical interventions for 
BPH with modern medicines are not free from side effects. So in this age group, there is a 
need for safer alternative method of management. Total 10 patients having signs and 
symptoms of mootraghata / BPH were selected from OPD and IPD of Shalya Tantra. In this 
regard, herbal drug Kanchanar Guggulu (500 mg TID orally), and Dhanyaka Gokshura 
Ghrita matra basti (60 ml OD) tried in this study.  The treatment was given for 21 days and 
assessed as per gradation adopted. Finally study has concluded that Kanchanar Guggulu & 
Dhanyaka Gokshura Ghrita matra basti is effective in symptomatic relief in mootraghata. 
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Introduction: 
Benign Prostatic Hyperplesia is 
excessive growth of prostatic tissue and is 
found mostly in old age men which affects 
above the age of 40 years. (1)
 
 In modern 
medicine the management of BPH is 
hormonal therapy, chemotherapy and 
finally surgical interventions like open 
prostatectomy, Trans Urethral Resection of 
Prostate (TURP), cryotherapy. (2)
 
  In old 
age the surgery is associated with many 
complications like postoperative 
morbidity, impotence, retrograde 
ejaculation and sometimes incontinence of 
urine.
 
(3)
  
   
In classics the causes of 
mootraghata are deranged function of 
vayu, particularly apana vayu and basti 
(matra basti) is authentic treatment for 
vitiated vayu.(4)  In samprapti 
(pathogenesis) of  mootraghata (BPH) 
mootravaha srotodushti leads due to 
vitiation of vata and kapha dosha.  So, 
Vata kapha Shamaka drugs along with 
matra basti help in reducing the size of the 
prostate and enhancing the tone of urinary 
bladder. Considering these properties, 
herbal drug Kanchanar Guggulu and 
Dhanyaka Gokshura Ghrita for matra 
basti were tried in this study. (5, 6)
  
The 
aim and objective of this study is to 
validate the effect of Kanchanar Guggulu 
and Dhanyaka Gokshura Ghrita matra 
basti in the management of 
mootraghata/BPH. 
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Materials and methods: 
Total 10 patients having signs and 
symptoms of mootraghata / BPH were 
selected from OPD and IPD of Shalya 
Tantra.  
 
Inclusion Criteria: 
Male patients of age above 50 
years having signs and symptoms of 
mootraghata (BPH) were included in this 
study. 
 
Exclusion Criteria: 
Patients below 50 years of age are 
excluded. Patients suffering from 
malignancy,  
Systemic diseases like 
Uncontrolled Hypertension (HT) & 
Diabetes Mellitus (DM), Tuberculosis 
(TB), Paralysis, and Parkinsonism etc. 
were excluded from study. 
 
Interventions: 
Orally: Kanchanar Guggulu was 
administered in dose of 500 mg, three 
times (TID) with luke warm water, half an 
hour before breakfast. 
Matra basti:  Dhanyaka Gokshura Ghrita 
was administered in 60 ml once daily as 
matra basti, just before breakfast. 
 
Procedure of Matra Basti: 
In most of the patients matra basti 
was given after getting admitted in 
SHMW.  
 
1. Poorva Karma: 
 Patients advised to pass their 
natural urges prior to matra basti. 
 All patients advised nil orally 
before the administration of matra 
Basti.  
 Drugs required for matra basti like 
DGG were boiled before 
administration.  
 Instruments like rubber catheter, 
20cc syringe, gloves were kept 
ready.  
 
2. Pradhana Karma: 
 Patient was asked to lie in left 
lateral position on table. 
 The Dhanyaka Gokshura Ghrita 
(DGG)  is cooled to room 
temperature. 
 Slowly and steadily 60ml DGG 
was administered through rectal 
route with plastic syringe and 
rubber catheter lubricated with 
ghrita. 
 At the time of insertion of the 
ghrita patient was asked to inhale 
and exhale deeply and keep himself 
as relaxed as possible. 
 
3. Pashchata Karma: 
 After matra basti patients advised 
to lie down in left lateral position 
for 10 minutes.  
 Patient was tapped on back and 
legs were kept in bending position. 
 Dinner was allowed only after 
matra basti. 
 Patient shifted to ward and hot 
water bag was provided for local 
Swedana (fomentation) at lower 
abdomen. 
 All the patients asked to note the 
time of pratyagamana kala (time 
of retention) of basti. 
 
Ethical clearance: Institutional ethics 
committee vide letter no.PGT/7-
A/Ethics/2011-12/2087 Serial No. 38, 
dated 5/9/2010. 
 
CTRI Registration:  Trial 
Acknowledgement Number 
REF/2013/03/004818 
 
Criteria for assessment: 
Subjective Criteria: The symptoms of 
BPH were assessed by adopting 
International Prostate Symptom Score 
(IPSS). (7)
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Table 1: Subjective Criteria by Scoring 
Pattern:  
Nocturia 
Up to2 times 0 
>3 to 5 times 1 
>5 to 7 times 2 
> 7 times 3 
Increased Frequency of Urination 
Up to 5 times 0 
>5 to 7 times 1 
>8 to 10 times 2 
> 10 times 3  
Urgency 
Absent 0 
Occasionally 1 
Often (in day time) 2 
Always (in day & night) 3 
Dribbling 
Absent 0 
Occasionally 1 
Often (in day time)  1 
Always (in day & night) 3 
Burning Micturation 
Absent 0 
Occasionally 1 
Often (in day time) 2 
Always (in day & night) 3 
Dysuria 
No difficulty in micturation 0 
Difficulty in micturation>2 times 1 
Difficulty in micturation>4 times 2 
Difficulty in micturation always 3 
Haematuria 
Absent 0 
Microscopic presence of RBC up to 
10 
1 
Smokey Urine ( RBCs- 10 to 20) 2 
Always reddish urine ( RBC- plenty) 3 
 
 
 
Incomplete Voiding 
Absent 0 
Occasionally 1 
Often ( in day time) 2 
Always ( in day & night) 3  
Weak Urine Stream (Stop & Start 
Absent 0 
Occasionally 1 
Often ( in day time) 2 
Always ( in day & night) 3 
 
Objective Criteria:   
The assessment of prostate size and 
Post-void residual urine volume (PVRU) 
was done with the help of USG. The 
average urine flow rate (AUFR) was 
measured manually. 
 
Table 2: Objective Criteria Score 
Pattern 
Residual Urine Volume 
Nil (up to 30 cc) 0 
> 30  to 60 cc 1 
>60  to 90 cc 2 
>90  to 120 cc 3 
> 120  cc 4 
Urine Flow Rate 
Normal or More  (≥15 ml/Sec) 0 
11  to < 15  ml/Sec 1 
 07 to  <11 ml/Sec 2 
03  to <07 ml/Sec 3 
00 to < 03 ml/Sec 4 
Prostrate size (volume) 
 Up to Normal (14-26 cc) 0 
>  26  to  36 cc 1 
> 36   to  46  cc 2 
> 46   to  56 cc 3 
> 56 cc 4 
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Table 3: International prostate symptom score (IPSS)  
IPSS 
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Incomplete emptying 
Over the past month, how often have you 
had a sensation of not emptying your 
bladder completely after you finish 
urinating? 
0 1 2 3 4 5   
Frequency 
Over the past month, how often have you 
had to urinate again less than two hours 
after you finished urinating? 
0 1 2 3 4 5   
Intermittency 
Over the past month, how often have you 
found you stopped and started again 
several times when you urinated? 
0 1 2 3 4 5   
Urgency 
Over the last month, how difficult have 
you found it to postpone urination? 
0 1 2 3 4 5   
Weak stream 
Over the past month, how often have you 
had a weak urinary stream? 
0 1 2 3 4 5   
Straining 
Over the past month, how often have you 
had to push or strain to begin urination? 
0 1 2 3 4 5   
Nocturia 
Over the past month, many times did you 
most typically get up to urinate from the 
time you went to bed until the time you 
got up in the morning? 
0 1 2 3 4 5   
Total IPSS score   
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Quality of life due to urinary 
symptoms 
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If you were to spend the rest of your 
life with your urinary condition the 
way it is now, how would you feel 
about that? 
0 1 2 3 4 5 6   
 
Total score: 
0-7 Mildly Symptomatic 
8-19 Moderately Symptomatic 
20-35 Severely Symptomatic 
 
Table 4: Criteria for Overall assessment: 
Complete Cure  100%  Relief in subjective, objective findings and IPSS parameters  
Maximum 
Improvement 
76 to <100% Relief in subjective, objective findings and IPSS 
parameters 
Moderate Improvement 51 to 75% Relief in subjective, objective findings and IPSS 
parameters 
Mild Improvement 26 to 50% Relief in subjective, objective findings and IPSS 
parameters 
Unchanged Up to 25 % Relief in subjective, objective findings and IPSS 
parameters 
 
OBSERVATIONS AND RESULTS: 
 
Table 5: Observation on demographic data   (n=10) 
 
Observation No. of patients  % 
Age ( 61-70) 7 70.00 
Religion (Hindu) 10 100.00 
Socio economic status (middle 
class) 
4 
40.00 
Occupation (Retired) 6 60.00 
Diet habit (Samashana) 5 50.00 
Bowel habit (Irregular) 5 50.00 
Chronicity (up to 1 year) 6 60.00 
Prakriti ( Vata-kapha) 4 40.00 
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Table 6: Observation on Symptoms:    (n =10)        
                                                                                      
Symptoms No. of patients Percentage (%) 
Nocturia  9 90.00 
Increased Frequency  8 80.00 
Dribbling   5 50.00 
Heamaturia  0 00.00 
Burning Micturation  9 90.00 
Dysuria  8 80.00 
Incomplete Voiding  7 70.00 
Weak Stream  9 90.00 
Urgency 6 60.00 
     
Table 7: Observation on Local Findings    (n=10) 
 
Observations No. of patients  % 
Enlargement of lobes (Bilateral) 6 60.00 
Shape (Oval & round) 5 50.00 
Surface (Smooth) 9 90.00 
Upper border of gland (Reached) 7 70.00 
Median groove (Palpable) 7 70.00 
Mobility (Fixed) 10 100.00 
Rectal mucosa (Free) 10 100.00 
Consistency (Soft) 6 60.00 
Tenderness (Absent) 9 90.00 
Size (Mild & moderate) 5 50.00 
 
 
Table 8: Effect of therapy on IPSS       
 
International Prostate 
Symptoms Score (AUA) 
Mean 
Score n 
% 
Relief 
SD SE t p 
BT AT 
Incomplete emptying 4.3 0.8 6 80.76 1.760 0.718 4.869 <0.001 
Frequency 5.0 1.3 8 72.50 1.597 0.564 6.416 <0.001 
Intermittency 4.2 0.7 7 83.33 1.133 0.428 8.333 <0.001 
Urgency 4.5 1.5 6 66.66 1.897 0.774 3.872 <0.001 
Weak stream 4.3 1.5 8 65.71 1.959 0.692 4.150 <0.001 
Straining 3.7 1.0 7 76.92 1.951 0.737 3.872 <0.001 
Nocturia 4.0 0.6 9 83.33 1.732 0.577 5.773 <0.001 
Quality of life 5.1 1.4 9 71.73 1.224 0.408 8.981 <0.001 
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Table 9: Effect of therapy on Objective parameters:    (n=10) 
 
Objective Parameters 
Mean Score % 
Relief 
SD SE t P 
BT AT 
Prostate size & Volume 34.55 31.22 9.63 7.130 2.377 1.400 <0.05 
Post-voidal  Residual Urine 
Volume (PVRU) 
49.89 13.89 72.16 56.60 18.86 1.908 <0.05 
Average Urine Flow Rate 1.79 3.65 50.81 1.599 0.533 3.477 <0.01 
 
 
Table10: Overall Effect of Therapy:     (n=10) 
 
Overall Effect No. of Patients  % 
Complete cured 0 00.00 
Maximum Improvement 4 40.00 
Moderate Improvement 4 40.00 
Mild Improvement 2 20.00 
Unchanged 0 00.00 
 
 
Discussion: 
 The mootraghata is a broad term 
and it can be considered as a syndrome, 
because it covers most of the pathological 
entity of the urinary system into twelve 
types. (8)
  
These types may be co-related 
with three major groups of modern 
parlance i.e. Neurogenic Bladder 
Distubances (NBD), Bladder Outflow 
Obstruction (BOO) & Lower Urinary 
Tract Symptoms (LUTS). Most of the 
patients in this study (46.66%) were from 
the age-group of 61-70 years as BPH is a 
disease related to aging. 60.00% of patient 
had chronicity of BPH up to 1 year which 
suggested that slow progressive nature of 
BPH. Maximum patients have the history 
of taking madhura rasa (86.67%), snigdha 
guna (80.00%) & laghu guna (83.33%) 
dominant diet. These types of food 
increased vata & kapha dosha in the body 
which are the actual causative factor for 
mootraghata. Maximum i.e. 43.33 % of 
patients were belonging to vata-kaphaja 
prakriti which is important risk factor for 
susceptibility or development of 
mootraghata. (Table no.5) 
In this study, the symptoms of BPH 
like weak stream, nocturia and increased 
frequency was observed more than 90% of 
patients as these are cardinal symptoms of 
BPH (Table no.6).  The per rectal 
digital examination findings of BPH like 
smooth surface, upper border 
approachable, median grove palpable, soft 
consistency and free rectal mucosa all 
these signs were observed in most of the 
patients. These findings are suggestive that 
the selected patients had the benign 
enlargement of prostate and there was no 
possibility of malignant (Table no.7). 
 In this study all patients showed 
symptomatic relief and statistically showed 
highly significant result in most of 
symptoms (Table no.8). Kanchanar 
Guggulu which had vatkapha shamak 
properties
 
due to its pachana, 
bastishodhana, mootrala, grahee, 
pramathee and vata-kapha shamaka 
pharmacological actions which played 
vital role in breaching samprapti of 
mootraghata. The recent studies on 
Kanchanar Guggulu also proved in 
treating urinary disorder due to its 
kaempferol & quercitin flavonoids that 
prevent estrogen receptor conditions like 
urinary incontinence and urogenital 
atrophy. (9)
 
  In Kanchanar Guggulu most 
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of the ingredients like (Kanchanar, 
Haritaki, Bibhitaki, and Varun etc.) 
contains tannins which elevates Thyroid 
Stimulating Hormone (TSH), Luteinizing 
Hormone (LH) and serum testosterone 
level. The increased testosterone level 
inhibits the further growth of prostate 
gland. The ingredient like amalaki is rich 
in ascorbic acid which plays important 
role as antioxidant.  
In Ayurveda it is mentioned that 
matra basti is choice of treatment in 
controlling vata dosha in all types of 
mootraghata. (10)  The effect of matra 
basti was seen on apana vayu and effect of 
drug was shown as mootrala and 
vatakapha shamaka. It was also having the 
effect of basti shodhana which might have 
lead to easy release of mootra from basti. 
Matra basti has also given balya effect to 
the basti snayu which helped to improve 
the tone of bladder and ultimately resulted 
in samprapti vighatana of vata virddhi. In 
matra basti, gokshura one of the 
ingredient has beta-sitosterol, go ghirta & 
dhanyaka both contains linoleic acid and 
oleic acid. Beta-sitosterol is shown 
effective in symptoms like nocturia while 
linoleic acid and oleic acid inhibit 5-α 
reductase activity. (11,12) The inhibition 
of 5-α reductase controls the 
Dihydrotestosterone (DHT). So decrease/ 
controlling in DHT ultimately control the 
further growth of prostate gland and 
relieve symptoms of BPH.  
In objective parameters the size 
and volume of prostate as per USG finding 
showed mild decrease and statistical 
significant result were seen.  In case of 
post-void residual urine volume in 
individual patients before and after, was 
markedly reduced by 72.16% and showed 
significant result statistically (Table 
no.9).In average urine flow rate, highly 
significant result observed might be the 
obstruction of urine flow by improving the 
function of apana vayu.  Kanchanar 
Guggulu contains ascorbic acid which 
helps in relaxing the smooth muscle of 
bladder neck and prostate gland to relieve 
in pressure and improve the urine flow. 
The overall result showed that 40% 
patients were shown maximum 
improvement, 40% cases showed moderate 
improvement and 20 patients showed mild 
improvement in signs and symptoms. The 
complete cure was not observed in any 
patients as there is a structural change in 
prostate gland in old age. So it can be said 
that study showed positive effect of 
combined therapy in the management of 
BPH (Table no.10).   
 
Conclusion: 
Finally study was concluded that 
Kanchanar Guggulu orally (KG) & 
Dhanyaka Gokshura Ghrita Matra Basti 
(DGG MB) is safe and effective in 
symptomatic management of mootraghata 
(BPH). It was also concluded that further 
growth of the prostate grand can be 
controlled with this therapy. As this study 
is conducted on less number of patients 
and trans- rectal sonography (TRS) has 
been not performed. So it needs to be 
studied in more number of patients which 
assessed with TUR for concrete 
conclusion. There was no any adverse 
effect throughout the study. 
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